US 12091426
Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof
granted A61PA61P35/00A61P37/02
Quick answer
US patent 12091426 (Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof) held by NURIX THERAPEUTICS, INC. expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- NURIX THERAPEUTICS, INC.
- Grant date
- Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P35/00, A61P37/02